XRCC4 and cancer: Further, genetic variants such as the single nucleotide polymorphism p.Ala247Ser, and other XRCC4 mutations, contribute to cancer susceptibility in non‐BRCA1/2 breast cancer, oral cancer, and hepatocellular carcinoma in humans [26, 27, 28].